Polymorphisms in the Vitamin D Receptor (VDR) and the Risk of Ovarian Cancer: A Meta-Analysis

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Liu, Yanling ^a   Li, Chenglin ^a   Chen, Peizhan ^a   Li, Xiaoguang ^a   Li, Mian ^a   Guo, He ^a   Li, Jingquan ^a,b   Chu, Ruiai ^a,b   Wang, Hui ^a,b  

^a UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^b BEIJING HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR CDX2; VITAMIN D RECEPTOR;

APAL GENE; ARTICLE; BSML GENE; CANCER RISK; CDX 2 GENE; FOKI GENE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; OVARY CANCER; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TAQL GENE; VITAMIN D RECEPTOR GENE;

FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; OVARIAN NEOPLASMS; POLYMORPHISM, GENETIC; RECEPTORS, CALCITRIOL;

EID: 84879489665     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066716     Document Type: Article

References (40)

1. Jemal A, Bray F, (2011) Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Romero I, Bast RC Jr, (2012) Minireview: human ovarian cancer: biology, current management, and paths to personalizing therapy. Endocrinology 153: 1593-1602.
3. Brekelmans CT, (2003) Risk factors and risk reduction of breast and ovarian cancer. Curr Opin Obstet Gynecol 15: 63-68.
4. Spina CS, Ton L, Yao M, Maehr H, Wolfe MM, et al. (2007) Selective vitamin D receptor modulators and their effects on colorectal tumor growth. J Steroid Biochem Mol Biol 103: 757-762.
5. Garland CF, Garland FC, Gorham ED, Lipkin M, Newmark H, et al. (2006) The role of vitamin D in cancer prevention. Am J Public Health 96: 252-261.
6. Chen P, Hu P, Xie D, Qin Y, Wang F, et al. (2010) Meta-analysis of vitamin D, calcium and the prevention of breast cancer. Breast Cancer Res Treat 121: 469-477.
7. Baker AR, McDonnell DP, Hughes M, Crisp TM, Mangelsdorf DJ, et al. (1988) Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci U S A 85: 3294-3298.
8. Ahonen MH, Zhuang YH, Aine R, Ylikomi T, Tuohimaa P, (2000) Androgen receptor and vitamin D receptor in human ovarian cancer: growth stimulation and inhibition by ligands. Int J Cancer 86: 40-46.
9. Jiang F, Li P, Fornace AJ Jr, Nicosia SV, Bai W, (2003) G2/M arrest by 1,25-dihydroxyvitamin D3 in ovarian cancer cells mediated through the induction of GADD45 via an exonic enhancer. J Biol Chem 278: 48030-48040.
10. Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, et al. (1998) The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 13: 325-349.
11. Manolagas SC, Yu XP, Girasole G, Bellido T, (1994) Vitamin D and the hematolymphopoietic tissue: a 1994 update. Semin Nephrol 14: 129-143.
12. Grant DJ, Hoyo C, Akushevich L, Iversen ES, Whitaker R, et al. (2012) Vitamin D receptor (VDR) polymorphisms and risk of ovarian cancer in Caucasian and African American women. Gynecol Oncol.
13. Kostner K, Denzer N, Muller CS, Klein R, Tilgen W, et al. (2009) The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature. Anticancer Res 29: 3511-3536.
14. Lurie G, Wilkens LR, Thompson PJ, Carney ME, Palmieri RT, et al. (2011) Vitamin D receptor rs2228570 polymorphism and invasive ovarian carcinoma risk: pooled analysis in five studies within the Ovarian Cancer Association Consortium. International journal of cancer Journal international du cancer 128: 936-943.
15. Lurie G, Wilkens LR, Thompson PJ, McDuffie KE, Carney ME, et al. (2007) Vitamin D receptor gene polymorphisms and epithelial ovarian cancer risk. Cancer Epidemiol Biomarkers Prev 16: 2566-2571.
16. Mostowska A, Sajdak S, Pawlik P, Lianeri M, Jagodzinski PP, (2013) Vitamin D Receptor Gene BsmI and FokI Polymorphisms in Relation to Ovarian Cancer Risk in the Polish Population. Genet Test Mol Biomarkers 17: 183-187.
17. Tamez S, Norizoe C, Ochiai K, Takahashi D, Shimojima A, et al. (2009) Vitamin D receptor polymorphisms and prognosis of patients with epithelial ovarian cancer. Br J Cancer 101: 1957-1960.
18. Tworoger SS, Gate MA, Lee IM, Buring JE, Titus-Ernstoff L, et al. (2009) Polymorphisms in the Vitamin D Receptor and Risk of Ovarian Cancer in Four Studies. Cancer Research 69: 1885-1891.
19. Clendenen TV, Arslan AA, Koenig KL, Enquist K, Wirgin I, et al. (2008) Vitamin D receptor polymorphisms and risk of epithelial ovarian cancer. Cancer Lett 260: 209-215.
20. Tworoger SS, Gates MA, Lee IM, Buring JE, Titus-Ernstoff L, et al. (2009) Polymorphisms in the vitamin D receptor and risk of ovarian cancer in four studies. Cancer Res 69: 1885-1891.
21. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
22. Duval S, Tweedie R, (2000) Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56: 455-463.
23. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L, (2007) Performance of the trim and fill method in the presence of publication bias and between-study heterogeneity. Stat Med 26: 4544-4562.
24. Arai H, Miyamoto K, Taketani Y, Yamamoto H, Iemori Y, et al. (1997) A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. J Bone Miner Res 12: 915-921.
25. Jurutka PW, Whitfield GK, Hsieh JC, Thompson PD, Haussler CA, et al. (2001) Molecular nature of the vitamin D receptor and its role in regulation of gene expression. Rev Endocr Metab Disord 2: 203-216.
26. Raimondi S, Johansson H, Maisonneuve P, Gandini S, (2009) Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk. Carcinogenesis 30: 1170-1180.
27. Yin M, Wei S, Wei Q, (2009) Vitamin D Receptor Genetic Polymorphisms and Prostate Cancer Risk: A Meta-analysis of 36 Published Studies. Int J Clin Exp Med 2: 159-175.
28. Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP, (2004) Genetics and biology of vitamin D receptor polymorphisms. Gene 338: 143-156.
29. Mocellin S, Nitti D, (2008) Vitamin D receptor polymorphisms and the risk of cutaneous melanoma: a systematic review and meta-analysis. Cancer 113: 2398-2407.
30. Colin EM, Weel AE, Uitterlinden AG, Buurman CJ, Birkenhager JC, et al. (2000) Consequences of vitamin D receptor gene polymorphisms for growth inhibition of cultured human peripheral blood mononuclear cells by 1, 25-dihydroxyvitamin D3. Clin Endocrinol (Oxf) 52: 211-216.
31. van Etten E, Verlinden L, Giulietti A, Ramos-Lopez E, Branisteanu DD, et al. (2007) The vitamin D receptor gene FokI polymorphism: functional impact on the immune system. Eur J Immunol 37: 395-405.
32. Orlow I, Roy P, Reiner AS, Yoo S, Patel H, et al. (2012) Vitamin D receptor polymorphisms in patients with cutaneous melanoma. Int J Cancer 130: 405-418.
33. Bai YH, Lu H, Hong D, Lin CC, Yu Z, et al. (2012) Vitamin D receptor gene polymorphisms and colorectal cancer risk: a systematic meta-analysis. World J Gastroenterol 18: 1672-1679.
34. Xu L, Glass CK, Rosenfeld MG, (1999) Coactivator and corepressor complexes in nuclear receptor function. Curr Opin Genet Dev 9: 140-147.
35. Yamamoto H, Miyamoto K, Li B, Taketani Y, Kitano M, et al. (1999) The caudal-related homeodomain protein Cdx-2 regulates vitamin D receptor gene expression in the small intestine. J Bone Miner Res 14: 240-247.
36. John EM, Schwartz GG, Koo J, Van Den Berg D, Ingles SA, (2005) Sun exposure, vitamin D receptor gene polymorphisms, and risk of advanced prostate cancer. Cancer Res 65: 5470-5479.
37. Cheteri MB, Stanford JL, Friedrichsen DM, Peters MA, Iwasaki L, et al. (2004) Vitamin D receptor gene polymorphisms and prostate cancer risk. Prostate 59: 409-418.
38. Mikhak B, Hunter DJ, Spiegelman D, Platz EA, Hollis BW, et al. (2007) Vitamin D receptor (VDR) gene polymorphisms and haplotypes, interactions with plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D, and prostate cancer risk. Prostate 67: 911-923.
39. Rukin NJ, Luscombe C, Moon S, Bodiwala D, Liu S, et al. (2007) Prostate cancer susceptibility is mediated by interactions between exposure to ultraviolet radiation and polymorphisms in the 5′ haplotype block of the vitamin D receptor gene. Cancer Lett 247: 328-335.
40. Grant WB, (2012) Ecological studies of the UVB-vitamin D-cancer hypothesis. Anticancer Res 32: 223-236.